Exelixis (EXEL) Free Cash Flow (QoQ) (2010 - 2026)
Exelixis (EXEL) Free Cash Flow (QoQ) (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,583.17 Bn | 67,582.89 Bn | - |
| 2 | Nanobiotix | 1,947.22 Bn | 1,947.15 Bn | - |
| 3 | Akari Therapeutics | 1,132.35 Bn | 1,132.35 Bn | - |
| 4 | BeOne Medicines | 473.21 Bn | 468.42 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 123.29 Bn | 116.04 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 70.05 Bn | 61.29 Bn | 3.31 Bn |
| 7 | Belite Bio | 63.09 Bn | 63.09 Bn | - |
| 8 | Argenx Se | 56.63 Bn | 51.45 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.79 Bn | 37.79 Bn | - |
| 10 | Exelixis | 14.62 Bn | 13.85 Bn | 590.86 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 3, 2026 | -24.68% |
| Jan 2, 2026 | 15.07% |
| Oct 3, 2025 | 525.80% |
| Jul 4, 2025 | -77.86% |
| Apr 4, 2025 | -11.77% |
| Jan 3, 2025 | -10.21% |
| Sep 27, 2024 | 132.91% |
| Jun 28, 2024 | 91.06% |
| Mar 29, 2024 | 2,406.20% |
| Dec 29, 2023 | -102.37% |
| Sep 29, 2023 | -6.13% |
| Jun 30, 2023 | 58.93% |
| Mar 31, 2023 | 13.14% |
| Dec 30, 2022 | -39.09% |
| Sep 30, 2022 | 341.42% |
| Jul 1, 2022 | -83.26% |
| Apr 1, 2022 | 200.00% |
| Dec 31, 2021 | -57.68% |
| Oct 1, 2021 | -30.60% |
| Jul 2, 2021 | 520.66% |